CMS Launches Office of Health Technology Products to Steer AI and Interoperability Policy

The Centers for Medicare & Medicaid Services has established a new Office of Health Technology Products, giving the agency a dedicated home for artificial intelligence, interoperability, and digital health policy across the Medicare and Medicaid programs.

The move is one of the clearest signals yet that health technology has graduated from a niche concern to a central pillar of federal healthcare strategy. With telehealth utilization rebounding to new highs and the CPT 2026 code set formally recognizing remote monitoring and AI diagnostic services, the machinery of American healthcare reimbursement is being rebuilt around digital care.

Why it matters

Until now, digital health policy at CMS has been scattered across program offices, leaving vendors and health systems to navigate inconsistent guidance on AI tools, data exchange requirements, and virtual care billing. A single accountable office creates a front door — and, industry observers hope, a faster and more predictable path from innovation to coverage.

The office will oversee AI, interoperability, and digital health product policy across Medicare and Medicaid — a consolidation the industry has requested for years.

The wider policy picture

The launch lands amid a flurry of related activity: the CY2027 Physician Fee Schedule proposed rule with its first-ever "Software as a Medical Service" payment category, the FDA-CMS TEMPO pilot linking device evaluation to Medicare coverage, and the Fair Telehealth Billing Act taking aim at surprise facility fees for virtual visits.

Early tests for the new office will include how it handles coverage determinations for AI-enabled diagnostics and how quickly it can publish guidance vendors can actually build against. For a sector that raised $7.4 billion in the first half of 2026 alone, the stakes are not small.

Reporting: MarketScale digital health coverage, July 2026.